Acquisitions of Businesses (Tables)

9 Months Ended

Sep. 30, 2015

Schedule of Business Acquisitions, by Acquisition

Revenues contributed by the Arysta, CAS and Agriphar Acquisitions for the three and nine months ended September 30, 2015 were as follows:



(amounts in millions)	Three Months Ended September 30, 2015		Nine Months Ended September 30, 2015
Arysta	$	318.2	$	837.6
CAS	73.8		282.4
Agriphar	25.6		145.6
Total	$	417.6	$	1,265.6

As the integration of the Arysta, CAS and Agriphar Acquisitions continues, discrete revenues reported by our existing businesses are being effected by the integration process and are becoming less comparable to prior periods.

The Arysta, CAS and Agriphar Acquisitions had net (loss) income for the three and nine months ended September 30, 2015 as follows:



(amounts in millions)	Three Months Ended September 30, 2015			Nine Months Ended September 30, 2015
Arysta	$	(34.8	)	$	(100.6	)
CAS	(25.0		)	(52.5		)
Agriphar	3.3			25.7
Total	$	(56.5	)	$	(127.4	)

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the consideration transferred and transaction related costs incurred to acquire Arysta, CAS and Agriphar and the applicable amounts of identified assets acquired and liabilities assumed at the acquisition date:



(amounts in millions)	Arysta			CAS			Agriphar
Consideration
Cash, net	$	2,856.2		$	983.1		$	350.2
Equity Instruments	645.9			52.0			16.6
Derivative liability	—			—			3.5
Total Consideration	$	3,502.1		$	1,035.1		$	370.3

Transaction related costs	$	38.6		$	45.4		$	5.1

Identifiable Assets acquired and Liabilities Assumed
Accounts receivable	$	674.5		$	154.2		$	60.1
Inventories	295.7			132.1			42.7
Other current assets	132.2			19.1			0.4
Property, plant and equipment	110.0			24.8			31.7
Identifiable intangible assets	1,638.9			534.0			183.0
Other assets	38.2			11.4			4.5
Current Liabilities	(574.0		)	(69.7		)	(47.5		)
Non-current deferred tax liability	(488.5		)	(26.7		)	(64.9		)
Other long term liabilities	(74.2		)	(13.4		)	(9.0		)
Non-controlling interest	(31.0		)	—			—
Total identifiable net assets	1,721.8			765.8			201.0

Goodwill	1,780.3			269.3			169.3

Total purchase price	$	3,502.1		$	1,035.1		$	370.3

Business Acquisition, Pro Forma Information

The following unaudited pro forma summary presents consolidated information of the Company for the three and nine months ended September 30, 2015 and 2014, as if the Arysta Acquisition had occurred on January 1, 2014, excluding CAS and Agriphar from the 2014 results as these Acquisitions closed prior to 2015:



	Three Months Ended September 30,						Nine Months Ended September 30,
(amounts in millions)	2015			2014			2015			2014
Revenue	$	597.3		$	557.9		$	1,894.7		$	1,638.5
Net loss attributable to stockholders	$	(118.6	)	$	(18.5	)	$	(160.1	)	$	(130.5	)